INTRODUCTION
============

Enterovirus-Human Rhinovirus (EV-HRV) are single stranded RNA viruses of the picornavirus family and are the most common causes of colds in children and adults ([@B1]). EV-HRV commonly causes mild upper respiratory tract illnesses; however, in rare instances they can cause severe and potentially fatal conditions such as Acute Respiratory Distress Syndrome (ARDS).

In the past, these viruses were under-recognized as a significant pathogen in immunocompromised patients, but several recent prospective studies using nucleic acid testing have clearly demonstrated that Rhinoviruses are probably the most common respiratory viral pathogen in transplant recipients ([@B2]--[@B7]).

In this article, we present a young man who developed ARDS secondary to EV-HRV infection.

CASE SUMMARIES
==============

A 35--year-old man with a prior history of liver transplantation 18 months ago was admitted to the Intensive Care Unit (ICU) of our hospital with respiratory failure.

He presented with persistent fever, cough, and shortness of breath which had first began two months ago after returning from a trip to Karbala, Iraq. Despite prolonged outpatient treatment including antibiotic therapy during this period, there was progression of symptoms which required hospital admission and subsequent transfer to our center.

His past medical history was significant for ulcerative colitis and Primary Sclerosing Cholangitis (PSC) diagnosed 16 years ago leading to liver transplantation 18 months prior to admission. After transplantation, there were no major complications to this point and his medications consisted of prednisone (5 mg), mycophenolate (6 tablets) and tacrolimus (1 mg) per day.

At the time of admission, he was alert but febrile and tachypneic. His blood pressure was 100/60 mmHg, respiratory rate 35/min, temperature 38.5 degrees celsius, O~2~ sat 85%, PaO~2~ 45 mmHg, and FiO~2~ 0.20 (PaO~2~/FiO~2~ ratio: 225).

Complete blood count revealed white blood cells 14,300/mm^3^ with a left shift, platelets 38,900/mcl, SGPT 26U/L, SGOT 23U/L and procalcitonin of 0.72ng/ml.

Rales were heard in both lungs. Chest Radiography revealed pulmonary vascular congestion and bilateral alveolar infiltration ([Figure 1](#F1){ref-type="fig"}).

![Chest X-Ray showed diffuse opacities](Tanaffos-18-169-g001){#F1}

CT- Scan of the chest showed bilateral alveolar infiltration with Air Bronchogram and ground-glass opacification ([Figure 2](#F2){ref-type="fig"}).

![CT- Scan of the chest showed bilateral alveolar infiltration with Air Bronchogram and ground-glass opacification](Tanaffos-18-169-g002){#F2}

Transthoracic echocardiogram (Echo) was normal, and duplex ultrasound scan of the lower extremities was negative for thrombosis.

Non-invasive ventilation was started with concomitant Meropenem (1g q3h), Vancomycin (15 mg/kg q12h), Levofloxacin (750 mg q24h), Oseltamivir (75 mg q12h) and high dose trimethoprim/sulfamethoxazole. Concurrently, a pharyngeal swab for Influenza and other viruses, blood cultures, CMV PCR, Serum galactomannan, 1,3-BD Glucan, and cryptococcal antigen was sent ([Table 1](#T1){ref-type="table"}).

###### 

Laboratory data

  -------------------- --------------
  Swab for influenza   Neg
  CMV PCR VIRAL load   2466 copy/ml
  Blood culture        Neg
  Serum galactomanan   Neg
  1,3-BD Glucan        90
  Cryptococcal Ag      Neg
  -------------------- --------------

After 48 hours of treatment, there was no significant clinical improvement; therefore, Caspofungin and ganciclovir were added to the previous treatment regimen. Furthermore, bronchoscopy was performed with the multiplex amplified nucleic acid testing of the Bronchoalveolar Lavage (BAL) fluid positive only for rhinovirus with high titers, consistent with the pharyngeal swab. All other viral, bacterial, and fungal organisms were negative.

The diagnosis of Rhinovirus pneumonia causing ARDS was established. The patient gradually improved and discharged from hospital after 3 weeks.

DISCUSSION
==========

Enterovirus-Human Rhinovirus (EV-HRVs) are single stranded RNA viruses of the picornavirus family that commonly cause mild respiratory tract illness. However, in some cases they can cause severe and potentially fatal conditions such as aseptic meningitis, encephalitis, myocarditis, viral pneumonia, and ARDS ([@B8]--[@B11]).

The severity of respiratory symptoms in EV-HRV infection depends on the production of numerous pro-inflammatory cytokines and chemokines such as (interleukin) IL-1, IL-6 and IL-8 ([@B12]). These pro-inflammatory molecules cause airway inflammation.

ARDS is characterized by diffuse inflammation of the lung leading to severe respiratory distress and hypoxemia refractory to oxygen therapy. ARDS is a clinical phenotype that can be triggered by various etiologies including infection, trauma, and sepsis. It is associated with high mortality rates ranging from 25 to 58% ([@B13]--[@B15]).

Rhinovirus commonly affects the pediatric age group, patients with chronic lung disease, and those who might be immunocompromised including patients with HIV, leukemia, and organ transplants.

Very few reports of EV-HRV causing severe ARDS in adults have been described in the literature. The pathogenesis of the severe respiratory illness caused by Rhinoviruses is not clear ([@B11], [@B15]). Early identification of EV-HRV infection using multiplex PCR techniques can limit the use of antimicrobial agents in such patients. As demonstrated in this case, it is important to consider EVHRV in the differential diagnosis of pneumonia causing severe ARDS in immunosuppressed patients.

CONCLUSION
==========

It should be kept in mind that human rhinovirus infection may cause severe lower respiratory tract infection and ARDS.
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